Q16E (p.Gln16Glu) variant of ABL2 (Tyrosine-protein kinase ABL2)
Q16E (p.Gln16Glu) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes population frequency data.
Q16E (p.Gln16Glu) variant details
- p.Gln16Glu
- TOPMed rs1428804229
- gnomAD rs1428804229
- Missense
- Variant Prioritization Score for Impact Estimate 0.371
- REVEL 0.21
- CADD 22.30
- PolyPhen-2 0.01
- SIFT 0.06
- Population evidence available